According to Lexston Life Sciences latest financial reports the cash on hand of LEXT is $375.33K, an decrease of -13.46% to 2022. At the end of 2022 company had $433.72K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $375.33K | -13.46% |
2022 | $433.72K | -37.79% |
2021 | $697.18K | - |